Eli Lilly unhappy with NPPA

Eli Lilly unhappy with NPPA

FPJ BureauUpdated: Saturday, June 01, 2019, 10:28 AM IST
article-image

New Delhi: US pharma major Eli Lilly & Co expressed disappointment over decision of drug price controller NPPA to fix price of medicines that are not under price control, and called for a transparent consultative approach with all stakeholders before taking such a step. “We are surprised and disappointed by this unexpected action,” Eli Lilly and Co India MD Edgard A Olaizola said.

RECENT STORIES

Analysis: Anonymous Electoral Bonds Reined In — But What About Anonymous Cash Donations?

Analysis: Anonymous Electoral Bonds Reined In — But What About Anonymous Cash Donations?

Game-Changing Alliance: Ambani's Reliance Ventures Into Adani's Power For The First Time; Acquires...

Game-Changing Alliance: Ambani's Reliance Ventures Into Adani's Power For The First Time; Acquires...

SRM Contractors IPO Subscribed 86.57 Times On Last Day Of Bidding

SRM Contractors IPO Subscribed 86.57 Times On Last Day Of Bidding

Tax-Saving Tip From Zerodha CEO Nithin Kamath: 'If You're Married And Hindu..."; Here's How To Save...

Tax-Saving Tip From Zerodha CEO Nithin Kamath: 'If You're Married And Hindu...

Holy Cities Like Ayodhya, Varanasi Attracting Big Retail Brands: Report

Holy Cities Like Ayodhya, Varanasi Attracting Big Retail Brands: Report